Alzheimer's
Encuentros Interactivos: Dilenia Cruz recibe el reconocimiento Citizen Scientist Cultivator Honoree 2024 por su labor en salud cerebral
*”This story reposted in its entirely in the original posted language”*En un evento celebrado en la Conferencia de Optimización de Sitios GAP-Net 2025 en Miami, Florida, la Global Alzheimer’s Platform Foundation® reconoció a Dilenia Cruz como una de las figuras clave en la lucha contra enfermedades neurodegenerativas al otorgarle el prestigioso título de Citizen Scientist Cultivator […]
Alzheimer’s Data Challenge Names Winners for Innovative Biomarker Research Competition
Global Researchers Recognized for Trailblazing Projects in First-of-Its-Kind Data Competition Washington D.C., Mar. 27, 2025 – International non-profit organization The Global Alzheimer’s Platform Foundation® (GAP) in collaboration with the Scottish Funding Council’s Brain Health Alliance for Research Challenges (ARC) and the Alzheimer’s Disease Data Initiative proudly announced four winners of the Bio-Hermes Biomarker Data Challenge at the first Data […]
First-of-its-Kind Bio-Hermes-001 Data Challenge Summit Unveiling Innovative Alzheimer’s Biomarker Research on March 21
The Global Alzheimer’s Platform Foundation® (GAP) – which is focused on global game-changing dementia research working with the Scottish Funding Council’s Brain Health Alliance for Research Challenges (ARC) proudly announces the first-of-its-kind Data Challenge Summit which will unveil the results stemming from the Bio-Hermes-001 Biomarker Data Challenge. The research competition was launched in February of 2024 to allow researchers early access […]
The Examiner: ‘I don’t have the same frustrations’: Alzheimer’s patient awarded for participation in medical trial
John Peters said the clinical trial he participated in at the Kawartha Centre gave him parts of his life back. John Peters wasn’t surprised when he started having trouble remembering things — he knew both his father and grandfather battled with Alzheimer’s. “The only big difference was I never smoked,” said Peters. “I was not […]
Fox 13 Tampa Bay: Ironman athlete diagnosed with Alzheimer’s focuses on new finish line: ‘A time for hope’
By Allie Corey Published March 11, 2025 6:01pm EDT FOX 13 News Ironman athlete with Alzheimer’s sets a new goal FOX 13’s Allie Corey highlights Scott Berkheiser, who is inspiring others by competing in the Ironman Triathlon despite being diagnosed with early-onset Alzheimer’s at 55 years old. The Brief TAMPA, Fla. – The Ironman Triathlon is a grueling […]
Global Alzheimer’s Platform Foundation Welcomes Ichor Research to its Global Network
International non-profit expands research network to Syracuse to improvecommunity access to research opportunities Washington D.C., Mar. 10, 2025- Global Alzheimer’s Platform Foundation® (GAP) announces the addition of Ichor Research, a leading private a clinical research organization based in Syracuse, New York, to its global network of over 100 best-in-class research sites. Specializing in neurodegenerative clinical trials, […]
10 Tampa Bay: Tampa researcher wants to study your brain, detect early signs of Alzheimer’s
The free clinical trial at Axiom Brain Health in Tampa works to detect early signs of Alzheimer’s and other cognitive diseases, even years before symptoms appear. Author: Hannah Dineen Published: 4:04 PM EST March 6, 2025 Updated: 8:52 PM EST March 6, 2025 TAMPA, Fla. — It’s estimated nearly 7 million people in the U.S. are living with Alzheimer’s disease. […]
Staff Terminations at Department of Health & Human Services May Have Dire Consequences for the Future of Critical Research
Washington D.C., Feb. 18, 2025- The Global Alzheimer’s Platform Foundation ® (GAP) is gravely concerned over news of terminations of key leaders at the National Institute of Health and the Federal Drug Administration along with the firing of thousands of employees from the Department of Health and Human Services over the weekend. John Dwyer, the […]
Global Alzheimer’s Platform Foundation Announces Strategic Collaboration with Roche for the Transformative Bio-Hermes-002 Study
Washington D.C., Feb. 18, 2025 – The Global Alzheimer’s Platform Foundation® (GAP) is pleased to welcome Roche to the Bio-Hermes-002 study. This collaboration will enhance this unique, observational platform study that compares blood-based and digital biomarkers across a broad range of clinical cognitive conditions, MRI and PET images as well as numerous races and ethnicities […]
CMO 360: A CMO’s Perspective on Designing Clinical Trials for a CNS Device
Ralph Kern, MD, MHSc, CMO of Cognito Therapeutics, discusses scaling up clinical trials, integrating patient centricity and transitioning from therapeutics to device treatments. February 13, 2025 Tell us about the scientific foundation behind the Spectris ADTM device. Our non-invasive investigational Spectris ADTM device evokes 40 Hz brain gamma oscillations through audiovisual stimulation. It’s delivered in […]